tradingkey.logo

US STOCKS-Indexes touch over one-month low on growth and inflation uncertainty

ReutersFeb 25, 2025 5:45 PM

For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.

  • Lilly up on launching higher-dose, discounted Zepbound vials
  • Solventum rises after Thermo Fisher to buy unit for $4.1 bln
  • S&P 500, Dow, Nasdaq at over one-month low
  • Indexes down: Dow 0.01%, S&P 500 0.80%, Nasdaq 1.58%

Updates with mid-session trading

By Johann M Cherian and Sukriti Gupta

- Wall Street's main indexes fell to touch a more than one-month low on Tuesday after fresh economic data indicated consumer mood was deteriorating and investors braced for a possible fallout from tighter U.S. trade controls on Beijing.

The Conference Board said consumer confidence deteriorated in February at its fastest pace in three-and-a-half years, with estimates for 12-month domestic inflation surging amid worries that U.S. tariffs on imports would raise prices for households.

Investors flocked to Treasury bonds, sending the yield on the two-year note US2YT=RR to its lowest since November, helping real estate stocks .SPLRCR rise 1.4%.

Sectors which are expected to fare better despite economic uncertainty gained, with consumer staples .SPLRCS rising 1.9% and healthcare .SPXHC adding 0.3%.

"There has been a lot of talk about tariffs, but until we really know what (the) policy will end up being, the uncertainty is making it difficult for the bulls to really get any kind of control of this market," said Chris Zaccarelli, chief investment officer at Northlight Asset Management.

Tuesday's consumer confidence report reinforced worries that the domestic economy is stalling and the U.S. Federal Reserve is likely to be cautious about cutting interest rates.

U.S. Treasury Secretary Scott Bessent said the economy is more fragile under the surface than economic metrics suggest.

Interest-rate futures currently point to the central bank staying put on borrowing costs for the first half of the year, according to data compiled by LSEG.

Policymaker Thomas Barkin and Fed Vice Chair for Supervision Michael Barr are expected to speak through the day.

At 11:50 a.m. the Dow Jones Industrial Average .DJI fell 5.45 points, or 0.01%, to 43,455.76, the S&P 500 .SPX lost 47.97 points, or 0.80%, to 5,935.28, and the Nasdaq Composite .IXIC lost 304.07 points, or 1.58%, to 18,983.51.

A gauge tracking investor fear .VIX spiked to hit its highest in nearly a month and was last up 1.57 points at 20.51.

Seven of the S&P 500's 11 sectors traded lower, with communication services .SPLRCL leading declines with a 1.8% drop.

Investors also focused on a report that said the U.S. was planning further restrictions on Nvidia's chip exports to China and that Washington was consulting with allies about tightening chip curbs on Beijing.

Nvidia NVDA.O dropped 2.9% and an index tracking semiconductor stocks .SOX fell 1.9%.

Nvidia's results on Wednesday will be crucial for technology companies, as investors have questioned the industry's hefty artificial-intelligence spends, especially after low-cost competition from China's DeepSeek rattled markets in January.

The S&P 500 technology sector .SPLRCT is on track for its first quarterly decline since July 2023, if losses hold.

Crypto stocks fell, with Coinbase COIN.O down 8.3% and MicroStrategy MSTR.O down 11% tracking bitcoin BTC= prices, which touched their lowest since November.

Eli Lilly LLY.N rose 2.1% after the drugmaker said it has begun selling higher doses of its weight-loss drug Zepbound in vials in the U.S., at a discount to the injector-pen versions.

Solventum SOLV.N jumped 9.8% after drug manufacturer Thermo Fisher TMO.N said it will buy the company's purification and filtration business for about $4.1 billion.

Declining issues outnumbered advancers by a 1.07-to-1 ratio on the NYSE, and by a 2.07-to-1 ratio on the Nasdaq.

The S&P 500 posted 26 new 52-week highs and seven new lows, while the Nasdaq Composite recorded 31 new highs and 255 new lows.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI